Haemonetics Reports 2nd Quarter Fiscal 2016 Revenue of $220 Million and Adjusted EPS of $0.44, Affirms Recent Full Fiscal Year Guidance
Go back to Haemonetics Reports 2nd Quarter Fiscal 2016 Revenue of $220 Million and Adjusted EPS of $0.44, Affirms Recent Full Fiscal Year Guidance| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 102.84 -0.08 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.92 | 52 Week High | $39.41 | |||
| Open | $101.89 | 52 Week Low | $25.98 | |||
| Day High | $103.53 | P/E | 144.85 | |||
| Day Low | $101.25 | EPS | $0.71 | |||
| Volume | 581,580 | |||||
